ZYUS Life Sciences Corporation announced that it will receive $1,484,600 in funding on February 16, 2023. The company will issue common shares and non-convertible debt in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.01 CAD | -0.98% |
|
+1.00% | +12.22% |
![Consensus](/images/consensus_flch.gif)
1st Jan change | Capi. | |
---|---|---|
+12.22% | 52.66M | |
+34.01% | 51.07B | |
+33.84% | 38.86B | |
-8.02% | 38.78B | |
-8.98% | 26.69B | |
+12.56% | 26.35B | |
-19.62% | 19.46B | |
+39.18% | 13.58B | |
+31.47% | 12.46B | |
-3.40% | 11.75B |
- Stock Market
- Equities
- ZYUS Stock
- News ZYUS Life Sciences Corporation
- ZYUS Life Sciences Corporation announced a financing transaction